New award for prednisolone acetate 1% ophthalmic suspension with greenstone LLC. Period of performance is may 1, 2022 to april 30, 2023 with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79722D0007
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 90% complete
IDV ceiling
$15,335,733.05
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs' National Acquisition Center awarded a single-award indefinite-delivery contract to Greenstone LLC on May 1, 2022, with a ceiling value of $15,335,733.05 to supply Prednisolone Acetate 1% Ophthalmic Suspension. The contract runs from May 1, 2022 through April 30, 2023, with four one-year options extending the ultimate completion date to April 30, 2027. No set-aside was used.

The contract fulfills estimated annual requirements exceeding 350,000 bottles in various sizes, serving the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The ophthalmic suspension is a corticosteroid used to treat inflammatory eye conditions. The solicitation was posted on September 28, 2021, with a due date of October 28, 2021, and was implemented to ensure an uninterrupted domestic supply of the medication across multiple federal customer agencies. The contract also implements Executive Order 14398 on diversity, equity, and inclusion discrimination provisions.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00017 · Implementing EO 14398 DEI discrimination $0
Exercise an Option P00016 · Exercise option year 4, effective may 1, 2026 to april 30, 2027 for prednisolone acetate 1% ophthalmic suspension with greenstone LLC. $0
Add Subcontract Plan P00015 · Incorporation of mylan pharmaceuticals 2026 small business subcontracting plan for contract #36E79722D0007 - prednisolone acetate 1% ophthalmic suspension. $0
Supplemental Agreement for work within scope P00014 · Incorporation of 2026 federal ceiling prices into existing contract. The awarded national contract prices were reduced for two line items (ndcs 60758-0119-05… $0
Exercise an Option P00013 · Exercise option year 3, effective may 1, 2025 to april 30, 2026 for prednisolone acetate 1% ophthalmic suspension with greenstone LLC. $0
Add Subcontract Plan P00012 · Incorporation of mylan pharmaceuticals 2025 small business subcontracting plan for contract #36E79722D0007 - prednisolone acetate 1% ophthalmic suspension. $0
Other Administrative Action P00011 · Incorporation of 2025 federal ceiling prices into contract. The awarded national contract prices remain unchanged for all line items. $0
Exercise an Option P00010 · Exercise option year 2, effective may 1, 2024 to april 30, 2025 for prednisolone acetate 1% ophthalmic suspension with greenstone LLC. $0
Supplemental Agreement for work within scope P00009 · Modification for the supplemental changes to the CRF payment submittal and sales reporting requirements. $0
Other Administrative Action P00008 · Incorporation of 2024 federal ceiling prices into contract. The awarded national contract prices remain unchanged for all line items. $0
Add Subcontract Plan P00007 · Incorporation of 2024 small business subcontracting plan into contract 36E79722D0007 - prednisolone acetate 1% ophthalmic suspension. $0
Other Administrative Action P00006 · This modification is issued to incorporate the drug supply chain security act (DSCSA) language into the contract. $0
Exercise an Option P00005 · Exercise option year 1 effective may 1, 2023 to april 30, 2024 for prednisolone acetate 1% ophthalmic suspension with greenstone LLC. $0
Add Subcontract Plan P00004 · Incorporation of 2023 small business subcontracting plan into contract 36E79722D0007 - prednisolone acetate 1% ophthalmic suspension. $0
Supplemental Agreement for work within scope P00003 · Incorporation of 2023 federal ceiling prices. No changes to the national contract price. $0
Other Administrative Action P00002 · Administrative POC change. $0
Add Subcontract Plan P00001 · Incorporation of 2022 small business plan into contract 36E79722D0007 - prednisolone acetate 1% ophthalmic suspension. $0
Original award $0
Show all 18

Quick answers

Who was awarded contract 36E79722D0007?

36E79722D0007 was awarded to Greenstone LLC by National Acquisition Center (Headquarters) on May 1, 2022.

How much is contract 36E79722D0007 worth?

36E79722D0007's own ceiling is $15,335,733.

Who can order from contract 36E79722D0007?

36E79722D0007 is a single award indefinite delivery contract.

Was contract 36E79722D0007 competed?

The extent of competition for 36E79722D0007 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV